NCT00101231 2013-06-04
Flavopiridol in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or Chronic Myelogenous Leukemia
National Cancer Institute (NCI)
Phase 1 Terminated
National Cancer Institute (NCI)
National Cancer Institute (NCI)